The introduction of the General Data Protection Regulation (Regulation (EU) 2016/679) (“GDPR”) was a painful process for many companies as databases were stripped, new practices introduced and consents to hold data obtained. Some requests were ignored or forgotten, and valuable contact details had to be deleted. However, Patricia Barclay at Bonnacord believes that the changing rules on data transfer from the EU was a welcome reform for clinical trial practice.